Investigating vaccine access, hesitancy, and misinformation as part of infectious disease prevention strategies. A human T cell (blue) under attack by HIV (yellow). Credit: Seth Pincus, Elizabeth ...

Lancet Infectious Disease. 2025; DOI: 10.1016/S1473-3099 (25)00237-3 2 Paccoud O, Lanternier F. Olorofim: addressing unmet needs of patients with difficult-to-treat fungal infections.

This report describes three cases of clade Ib MPXV infection in pregnant women (one in each trimester of gestation) with molecular and histopathological evidence of transplacental transmission.

Lymphatic filariasis has undergone a remarkable transformation in India, evolving from a neglected tropical disease to a national priority. This shift is largely attributable to the consistent policy ...

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious disease R&D for the British pharma. | After nearly 25 years with Sanofi ...

Despite this, the institute may be under threat. A leaked FY 2026 HHS budget proposal suggested eliminating NINR entirely, leading to strong opposition from national nursing organizations.